The results of CardinALS showed utreloxastat failed to meet its main and secondary goals, including several disease-related ...

Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering ...

Columnist Dagmar Munn has managed the shift to a rollator, scooter, and other assistive devices that help her live a better ...

Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to ...

Philadelphia dad Eric Brunner was diagnosed with amyotrophic lateral sclerosis, the fatal disease known as ALS. He wants to ...

The Gilbert family's resilience in the face of ALS highlights the crucial role of informal caregivers in America.

But utreloxastat had little effect on ALS in the phase 2 trial. PTC powered the study to show whether twice-daily oral dosing ...

Instead of feeling down, Maya and Maceo focus on what's still possible, pushing the boundaries of what the preconceived ...

Jimmer Szatkowski, who opened Upstate New York’s first Chick-fil-A in 2018, has been dedicated to running his restaurant ...

To partner with the ALS community to drive the discovery of prevention strategies, treatments, and cures for ALS; provide ...

Navigating apprenticeship and adult learner funding can sometimes feel overwhelming. Yet, with the right tools and mindset, ...